These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9540780)

  • 1. [Prevention of the extension of distal deep venous thrombosis. A randomized controlled trial with a 6-month follow-up].
    Belcaro G; Laurora G; Cesarone MR; De Sanctis MT; Incandela L; Dugall M; Mezzanotte L
    Minerva Med; 1997 Dec; 88(12):507-14. PubMed ID: 9540780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study.
    Belcaro G; Nicolaides AN; Errichi BM; Cesarone MR; De Sanctis MT; Incandela L; Venniker R
    Angiology; 1999 Jul; 50(7):523-9. PubMed ID: 10431991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
    Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
    Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin.
    Partsch H; Blättler W
    J Vasc Surg; 2000 Nov; 32(5):861-9. PubMed ID: 11054217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
    Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
    J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 20 pregnant women with venous thromboembolic disease].
    Sun P; Dong DN
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
    Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
    Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group.
    Hamulyák K; Lensing AW; van der Meer J; Smid WM; van Ooy A; Hoek JA
    Thromb Haemost; 1995 Dec; 74(6):1428-31. PubMed ID: 8772214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Compression therapy in deep venous thrombosis].
    Manganaro A; Buda D; Ando G; Consolo F
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):57-60. PubMed ID: 11253342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duplex screening as a method of quality assurance of perioperative thromboembolism prophylaxis.
    Van Den Berg E; Bathgate B; Panagakos E; Lambrechts R; Hani M; Meissner A; Schröder M
    Int Angiol; 1999 Sep; 18(3):210-9. PubMed ID: 10688420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of deep vein thrombosis.
    Turpie AG
    Herz; 1989 Dec; 14(6):341-7. PubMed ID: 2695442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group.
    Heit JA; Berkowitz SD; Bona R; Cabanas V; Corson JD; Elliott CG; Lyons R
    Thromb Haemost; 1997 Jan; 77(1):32-8. PubMed ID: 9031445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin.
    Partsch H; Kechavarz B; Mostbeck A; Köhn H; Lipp C
    J Vasc Surg; 1996 Nov; 24(5):774-82. PubMed ID: 8918323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
    Delis KT; Hunt N; Strachan RK; Nicolaides AN
    Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Deep venous thrombosis--treatment].
    Fries R; Böhm M
    Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.